• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Visla Labs Raises $3M for AI Medical Diagnostics Platform for Radiology

by Jasmine Pennic 11/02/2018 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

 Visla Labs Raises $3M for AI Medical Diagnostics Platform for Radiology

Visla Labs, a San Francisco, CA-based AI medical diagnostics platform for radiology has raised $3M in seed funding led by Lux Capital with participation from former Twitter CEO and COO Dick Costolo and Adam Bain, as well as prominent healthcare experts and advisors. Founded in 2018 by serial entrepreneurs Kevin Quennesson, Wei-En Tan and Alessandro Sabatelli, Visla is collaborating with major hospitals, industry veterans, and award-winning physicians to re-invent the imaging experience with self-improving AI at its core. With its products, Visla seeks to enhance diagnostic accuracy and unlock the next generation of augmented radiology.

AI-Driven Diagnostics Lowers Costs

Medical imaging and diagnostics can be incredibly complex and time-consuming, resulting often in a high rate of inaccuracy. Driven by an aging global population, teleradiology firms and urgent care centers are increasingly supply constrained in meeting patient demands to deliver life-critical care. Visla’s AI products aim to deliver expert diagnosis at significantly lower costs and faster turnaround times.

Visla AI Platform Initial Outcomes/Results

Within six months, the company has experienced accelerated adoption globally. Early previews of the Visla technology are currently covering millions of lives in more than 30 clinical settings across the US and Asia and Visla’s AI engines have ingested and processed millions of live images. In one example with an existing partner, Visla enabled 50% fewer missed diseases while automating 80% of healthy diagnosis.

The startup plans to leverage the seed funding to grow its team, scale product features, gain regulatory approval and fuel expansion and growth.

“Our aim is to focus on the user, using the fastest and nimblest iteration to help in an industry where there is real need and potential to make a difference,” said Wei-En Tan, Ph.D., co-founder of Visla. “We’ve seen the fragmented nature of healthcare for both doctors and patients,  and we’re passionate about the opportunity to reimagine the process of radiology, so that it is efficient and simple for doctors, and cost-effective for everyone.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence, Artificial Intelligence (AI) Software Platform, Diagnostic Imaging, radiology, Visla Labs

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |